• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT351418J
Device Problems Malposition of Device (2616); Activation, Positioning or Separation Problem (2906)
Patient Problem Occlusion (1984)
Event Date 01/08/2021
Event Type  Injury  
Manufacturer Narrative
According to the gore(r) excluder(r) aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: endoprosthesis improper component placement.
 
Event Description
The following information was reported to gore: on (b)(6) 2021, the patient underwent endovascular treatment for an abdominal aortic aneurysm using gore(r) excluder(r) aaa endoprostheses.The patient's aortic neck was described to be angular.The device was deployed slightly above the right renal artery with the intention to subsequently bring down and reposition the device below both renal arteries.However, the device could not be repositioned and both renal arteries were covered by the device.The physician attempted to move the device down by constraining the device, but it was reported that the device became attached to the narrowed inner curvature of the aortic wall and could not be repositioned.Stents were placed in both renal arteries.Blood flow to both renal arteries was confirmed.A proximal type i endoleak was also discovered.It was decided the patient will be monitored and the procedure was completed.
 
Manufacturer Narrative
H.6.Results code 1: 213: a review of the manufacturing records for the device verified the lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11215162
MDR Text Key228211123
Report Number3007284313-2021-01232
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/15/2023
Device Catalogue NumberRLT351418J
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/08/2021
Initial Date FDA Received01/22/2021
Supplement Dates Manufacturer Received04/06/2021
Supplement Dates FDA Received04/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
-
-